Loading...
Olaparib — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Olaparib
2025-Q4
Comprehensive analysis of India’s olaparib export trade — suppliers, buyers, prices, routes, and every shipment record.
74
Shipments
$446K
Trade Value
28
Suppliers
19
Buyers
23
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/olaparib
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s olaparib trade — 2025-Q4
KEY TAKEAWAY
Olaparib 2025-Q4 exports total $446.0K across 23 countries, with AMRS HEALTHCARE PVT LTD commanding 70.7% market share.
TOTAL SHIPMENTS
74
2025-Q4
EXPORT VALUE
$446.0K
FOB USD
TOTAL QUANTITY
208.9K
units shipped
INDIAN SUPPLIERS
28
unique exporters
GLOBAL BUYERS
19
unique importers
DESTINATIONS
23
countries
MEDIAN UNIT PRICE
$19.54
per unit
TOP-5 SHARE
92.6%
of total USD
BRANDED SHARE
67.6%
50 shipments
DOSAGE FORMS
2
product types
6 KEY FINDINGS
1
AMRS HEALTHCARE PVT LTD is India's #1 Olaparib exporter with $315.4K (70.7% market share).→ §5, Indian Supplier Rankings
2
Olaparib reached 23 countries, with Venezuela as the top destination ($319.5K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 5260) — top 10 suppliers control 97.8% of exports.→ §5, Indian Supplier Rankings
4
84.2% of buyers (16 of 19) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (99.3%) across 2 dosage forms.→ §7, Price Benchmarks
6
23 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 AMRS HEALTHCARE PVT LTD leads in volume — how do 28 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian olaparib exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Olaparib report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial olaparib trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian olaparib suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Olaparib India trade report
Product scope
Olaparib
All variants merged — branded and generic formulations of olaparib
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
74
Every commercial olaparib trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $4.0K, Nov $409.0K, Dec $33.0K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$4.0K
Oct USD
7 shipments
2
$409.0K
Nov USD
+10226.2% MoM
3
$33.0K
Dec USD
-91.9% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 10226.2% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $4K, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $446K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $405K rise in Nov, $376K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $4K | 7 shipments |
| Nov | $409K | 39 shipments |
| Dec | $33K | 28 shipments |
| Q4 Total | $446K | 74 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Zimbabwe held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: PLEASANT EXPORTS maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import olaparib from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Venezuela absorbs 71.7% of India’s 2025-Q4 olaparib trade ($319.5K). Beyond the top 10 destinations, 23 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 9 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 23 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much olaparib India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$91K
20.5% of trade
9 countries · 26 shipments
Europe
$3K
0.7% of trade
3 countries · 9 shipments
Americas
$342K
76.6% of trade
4 countries · 23 shipments
Africa
$10K
2.3% of trade
6 countries · 15 shipments
Oceania
$10
0.0% of trade
1 countries · 1 shipments
Fig 4.1 Venezuela is the #1 corridor ($320K) — 23 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian olaparib it receives (light = low, dark = high). Orange arcs radiate from India to the top 23 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Venezuela | $320K | 12 | AMRS HEALTHCARE PVT LTD | $315K | GALAXY SUPER SPECIALITY | $4K | — | — |
| 2 | South Korea | $68K | 4 | SANDOZ PVT LTD | $68K | — | — | — | — |
| 3 | Jamaica | $12K | 3 | SHREE KRISHNA LIFECARE | $12K | DISTINCT IMPEX PVT LTD | $5 | — | — |
| 4 | Myanmar | $9K | 1 | WELLNESS PHARMA INTERNATIONAL | $9K | — | — | — | — |
| 5 | Brazil | $8K | 6 | SANSKRUTI PHARMA | $7K | VAMA LIFECARE PVT LTD | $623 | IKRIS PHARMA NETWORK PVT LTD | $275 |
| 6 | Sri Lanka | $7K | 3 | PLEASANT EXPORTS | $7K | — | — | — | — |
| 7 | Zimbabwe | $5K | 3 | 3S PHARMACEUTICALS INDIA PVT LTD | $5K | RUTVA MEDICARE | $561 | — | — |
| 8 | Kenya | $3K | 3 | R.S. SURGIPHARM PVT LTD | $2K | RMPL PHARMA LLP | $1K | — | — |
| 9 | Yemen | $3K | 1 | J.A. UNITED EXPORTS PVT LTD | $3K | — | — | — | — |
| 10 | Azerbaijan | $3K | 2 | LEOWIN HEALTHCARE LLP | $3K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 20.5% of USD — but Venezuela is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
71.7%
#1 country share
Venezuela alone
93.5%
Top 5 share
5 of 23 countries
99.8%
Top 15 share
Long tail of 8 countries = 0.2%
HHI 5390
Destination HHI
Highly concentrated
23
Countries served
Global pharma reach from India
9
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
28 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
AMRS HEALTHCARE PVT LTD ($315.4K, 70.7% share) and SANDOZ PVT LTD ($68.5K) together control 86.1% of India’s 2025-Q4 olaparib trade. The top 5 suppliers hold 92.6%. 28 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian olaparib suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 AMRS HEALTHCARE PVT LTD leads by $247K over SANDOZ PVT LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: HUMANKIND PHARMA is #19 by value but #2 by volume.
Fig 5.2 AMRS HEALTHCARE PVT LTD also leads by shipment count (11) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: HUMANKIND PHARMA moves from #2 by volume to #19 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 28 olaparib suppliers split into strategic segments
KEY TAKEAWAY
7 suppliers (25%) generate 95.4% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 AMRS HEALTHCARE PVT LTD and SANDOZ PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 95.4% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | AMRS HEALTHCARE PVT LTD | 1 | 1 | $315K |
| 2 | SANDOZ PVT LTD | 1 | 1 | $68K |
| 3 | SHREE KRISHNA LIFECARE | 1 | 1 | $12K |
| 4 | WELLNESS PHARMA INTERNATIONAL | 1 | 1 | $9K |
| 5 | SANSKRUTI PHARMA | 1 | 2 | $8K |
| 6 | PLEASANT EXPORTS | 1 | 1 | $7K |
| 7 | 3S PHARMACEUTICALS INDIA PVT LTD | 1 | 2 | $6K |
| 8 | GALAXY SUPER SPECIALITY | 1 | 1 | $4K |
| 9 | LEOWIN HEALTHCARE LLP | 1 | 2 | $3K |
| 10 | J.A. UNITED EXPORTS PVT LTD | 1 | 2 | $3K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the olaparib manufacturing hubs
KEY TAKEAWAY
Noida and Navi Mumbai together account for $350K of India’s 2025-Q4 olaparib trade.
Fig 5.5 Noida (2 exporters, $316K) and Navi Mumbai (1 exporters, $34K) are India’s olaparib capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
92.6%
Top 5 share
5 of 28 suppliers
97.8%
Top 10 share
10 of 28 suppliers
95.4%
Top 25% share
7 suppliers = 95% USD
HHI 5260
Supplier HHI
Concentrated
28
Total suppliers
shipped Olaparib in 2025-Q4
16+ cities
Indian hubs
Noida and Navi Mumbai lead
§5.2 Coming next: 1 exporter deep-dive profiles
Each of the top 1 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | SANSKRUTI PHARMA | $8K |
#5
2025-Q4 USD
$8K
1.8% market share
SHIPMENTS
7
avg $1K/ship
COUNTRIES
2
destination markets
BUYERS
2
unique importers
BRANDED
100%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Brazil is the #1 market at $7K (87% of trade), followed by Burkina Faso at $1K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Brazil | $7K | 2 | 87.1% |
| 2 | Burkina Faso | $1K | 5 | 12.9% |
MONTHLY TREND
Nov peaked at $8K. Oct was the weakest at $0.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 0 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Burkina Faso | $4K | N/A |
| Undisclosed buyer | Burkina Faso | $4K | N/A |
#5
EXPORTER PROFILE #1 OF 1 — TRADE FLOW MAP
SANSKRUTI PHARMA — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P1.3 Brazil absorbs $7K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
19 importers across 23 countries — who is buying Indian olaparib and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 17 importers together hold only 14.5% of total USD. 84% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian olaparib. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 LEE HEE YOUNG is the #1 importer at $34K (7.7%) — top 17 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 17 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
84%
Single-source
16 buyers rely on exactly 1 Indian supplier
5%
Dual-source
1 buyers use 2 Indian suppliers
5%
Multi-source (3–4)
1 buyers diversified across 3–4
5%
Broad-source (5+)
1 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source olaparib from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Jamaica 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| JACQUELINE BROWN-BARNES | SHREE KRISHNA LIFECARE | $12K | $2K | Tablet |
| MARILYN LAMEY | SHREE KRISHNA LIFECARE | $8.405 | $4.203 | Tablet |
Zimbabwe 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| FOR THE ORDER OF* | 3S PHARMACEUTICALS I… | $3K | $166.042 | Tablet |
| /FOR THE ORDER OF | 3S PHARMACEUTICALS I… | $2K | $152.033 | Tablet |
Bahamas 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| FOR THE ORDER OF | 3S PHARMACEUTICALS I… | $1K | $50.892 | Tablet |
| PROGRESSIVE PHARMACEUT… | SPR ONCOCARE PVT LTD | $896.557 | $74.713 | Tablet |
Brazil 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| TO THE | VAMA LIFECARE PVT LTD | $623.290 | $155.823 | Tablet |
| SELMA APARECIDA DE ASSIS | NIVIRA EXPORTS | $6.014 | $1.002 | Tablet |
China 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| TONG LOGISTICS CO LTD | DRREDDYS LABORATORIE… | $39.089 | $19.544 | Tablet |
| DR REDDYS (BEIJING) PH… | DRREDDYS LABORATORIE… | $39.089 | $19.544 | Tablet |
§6.3 Price positioning — top 17 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | LEE HEE YOUNG | South Korea | $34K | $17K | Mid |
| 2 | JACQUELINE BROWN-BAR… | Jamaica | $12K | $12K | Budget |
| 3 | THE ESSES PHARMACY (… | Sri Lanka | $7K | $2K | Budget |
| 4 | FOR THE ORDER OF* | Zimbabwe | $3K | $3K | Budget |
| 5 | AL-NOOR FOR DRUGS & … | Yemen | $3K | $2K | Budget |
| 6 | /FOR THE ORDER OF | Zimbabwe | $2K | $2K | Budget |
| 7 | FOR THE ORDER OF | Bahamas | $1K | $1K | Budget |
| 8 | PROGRESSIVE PHARMACE… | Bahamas | $896.557 | $897.000 | Budget |
| 9 | TO THE | Brazil | $623.290 | $623.000 | Budget |
| 10 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | $581.313 | $65.000 | Budget |
| 11 | SOVEREIGN SPEED FRA … | Germany | $379.794 | $127.000 | Budget |
| 12 | TONG LOGISTICS CO LTD | China | $39.089 | $20.000 | Budget |
| 13 | DR REDDYS (BEIJING) … | China | $39.089 | $20.000 | Budget |
| 14 | PHAROS LTD | Greece | $12.283 | $6.000 | Budget |
| 15 | ALAIN DESIRE VICTOR … | New Zealand | $9.909 | $10.000 | Budget |
| 16 | MARILYN LAMEY | Jamaica | $8.405 | $8.000 | Budget |
| 17 | SELMA APARECIDA DE A… | Brazil | $6.014 | $6.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 17 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 AMRS HEALTHCARE PVT LTD → LEE HEE YOUNG is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 17 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian olaparib prices vary by supplier, country and dosage form
KEY TAKEAWAY
Olaparib prices span 45209× ($0.044 → $2008.83). The coefficient of variation is 2.98. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.044 | Lowest observed unit price |
| P5 | $0.330 | 5th percentile |
| P25 | $1.62 | 25th percentile (Q1) |
| Median | $19.54 | 50th percentile (Q2) |
| P75 | $73.10 | 75th percentile (Q3) |
| P95 | $162.11 | 95th percentile |
| Max | $2.0K | Highest observed unit price |
| Mean | $86.21 | Arithmetic average |
| CV | 298% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 SHREE KRISHNA LIFECARE prices at $1K/unit vs market median $19.54.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. AMRS HEALTHCARE PVT Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. SHREE KRISHNA LIFECARE Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. RMPL PHARMA LLP Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. WELLNESS PHARMA INTERNATIONAL Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | SHREE KRISHNA LI… | Jamaica | Tablet | 6 | $12K | $2K | Specialty / small-batch |
| Dec 2025 | WELLNESS PHARMA … | Myanmar | Tablet | 10 | $9K | $904.00 | Specialty / small-batch |
| Dec 2025 | 3S PHARMACEUTICA… | Zimbabwe | Tablet | 19 | $3K | $166.04 | Specialty / small-batch |
| Nov 2025 | GALAXY SUPER SPE… | Venezuela | Tablet | 25 | $4K | $164.49 | Specialty / small-batch |
| Nov 2025 | HEET HEALTHCARE … | Poland | — | 5 | $798.63 | $159.73 | Specialty / small-batch |
| Nov 2025 | HEET HEALTHCARE … | Poland | — | 5 | $798.63 | $159.73 | Specialty / small-batch |
| Nov 2025 | HEET HEALTHCARE … | Poland | — | 5 | $798.63 | $159.73 | Specialty / small-batch |
| Nov 2025 | VAMA LIFECARE PV… | Brazil | Tablet | 4 | $623.29 | $155.82 | Specialty / small-batch |
| Dec 2025 | 3S PHARMACEUTICA… | Zimbabwe | Tablet | 11 | $2K | $152.03 | Specialty / small-batch |
| Nov 2025 | LEOWIN HEALTHCAR… | Azerbaijan | Tablet | 10 | $1K | $149.74 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | SUSHEN MEDICAMEN… | Greece | Powder | 64 | $2.84 | $0.044 | Small sample / trial shipment |
| Dec 2025 | HUMANKIND PHARMA | United Arab Emirates | Tablet | 20 | $5.92 | $0.296 | Small sample / trial shipment |
| Dec 2025 | HUMANKIND PHARMA | United Arab Emirates | Tablet | 20 | $5.92 | $0.296 | Small sample / trial shipment |
| Nov 2025 | HUMANKIND PHARMA | United Arab Emirates | Tablet | 20 | $6.59 | $0.330 | Small sample / trial shipment |
| Nov 2025 | HUMANKIND PHARMA | United Arab Emirates | Tablet | 20 | $6.59 | $0.330 | Small sample / trial shipment |
| Dec 2025 | J.A. UNITED EXPO… | Egypt | Tablet | 100 | $34.85 | $0.349 | Small sample / trial shipment |
| Dec 2025 | HUMANKIND PHARMA | United Arab Emirates | Tablet | 20 | $8.40 | $0.420 | Small sample / trial shipment |
| Dec 2025 | HUMANKIND PHARMA | United Arab Emirates | Tablet | 20 | $8.40 | $0.420 | Small sample / trial shipment |
| Oct 2025 | YOGI CARE PHARMA… | DR Congo | Tablet | 2 | $0.862 | $0.431 | Small sample / trial shipment |
| Dec 2025 | SANSKRUTI PHARMA | Burkina Faso | Tablet | 12 | $6.69 | $0.558 | Small sample / trial shipment |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship olaparib, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Olaparib leaves India through 6+ ports. The top 5 (DELHI AIR, MUMBAI AIR (SAHAR), CHENNAI AIR) handle 100.0% of total USD. AIR moves 97% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 DELHI AIR handles $320K — top 6 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 CARACAS is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 97% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$446K
100.0% of USD · 97.3% of ships
SEA
$80
0.0% of USD · 2.7% of ships
Fig 8.3 The dominant corridor is DELHI AIR → Air → LatAm ($320K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Burkina Faso is the most concentrated destination (HHI 10000, 1 suppliers). United Arab Emirates is the most competitive (HHI 5003).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Burkina Faso (HHI 10,000) is the most concentrated — United Arab Emirates (HHI 5,003) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| LEE HEE YOUNG | South Korea | SANDOZ PVT LTD | $34K | 2 | MEDIUM |
| JACQUELINE BROWN-BAR… | Jamaica | SHREE KRISHNA LI… | $12K | 1 | MEDIUM |
| THE ESSES PHARMACY (… | Sri Lanka | PLEASANT EXPORTS | $7K | 3 | MEDIUM |
| FOR THE ORDER OF* | Zimbabwe | 3S PHARMACEUTICA… | $3K | 1 | MEDIUM |
| AL-NOOR FOR DRUGS & … | Yemen | J.A. UNITED EXPO… | $3K | 2 | MEDIUM |
| /FOR THE ORDER OF | Zimbabwe | 3S PHARMACEUTICA… | $2K | 1 | MEDIUM |
| FOR THE ORDER OF | Bahamas | 3S PHARMACEUTICA… | $1K | 1 | MEDIUM |
| PROGRESSIVE PHARMACE… | Bahamas | SPR ONCOCARE PVT… | $897 | 1 | MEDIUM |
Conclusion: 16 buyers depend on exactly one Indian supplier, representing $64K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Venezuela | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| South Korea | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Jamaica | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Myanmar | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Brazil | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Zimbabwe | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Yemen | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Azerbaijan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Poland | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Bahamas | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Burkina Faso | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Germany | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 13 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in South Korea | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Burkina Faso lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Venezuela (2 suppliers) | This Q | HIGH |
| A6 | Enter South Korea (1 suppliers) | This Q | MED |
| A8 | Build South Korea distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Venezuela tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Venezuela | Other | 2 | $320K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | South Korea | Asia | 1 | $68K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Zimbabwe | Africa | 2 | $5K | +760% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Jamaica | Other | 2 | $12K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Myanmar | Asia | 1 | $9K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Brazil | Other | 5 | $8K | 0% | LOW | Low competition (5 suppliers), accessible market |
| 7 | Sri Lanka | Asia | 1 | $7K | +0.3% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Kenya | Africa | 2 | $3K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Yemen | Other | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Azerbaijan | Other | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Poland | Other | 2 | $3K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Bahamas | Other | 2 | $2K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Burkina Faso | Africa | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | United Arab Emirates | Other | 2 | $581 | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Germany | Other | 1 | $380 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 74 2025-Q4 Olaparib shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/olaparib
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 74 2025-Q4 olaparib shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian olaparib shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
74
across all regions
TOTAL USD
$446K
2025-Q4 FOB value
UNITS
208.9K
tablets, capsules, etc.
SUPPLIERS
28
Indian exporters
BUYERS
19
global importers
COUNTRIES
23
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $10K (2.3%), spanning 6 countries.
28 Indian suppliers shipped to 19 buyers across 23 countries — average shipment value $6K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
6 countries · 15 shipments · $10K · 8 Indian suppliers · 5 buyers
SHIPMENTS
15
USD
$10K
COUNTRIES
6
SUPPLIERS
8
BUYERS
5
HHI
3,024
concentrated
Top 6 destination countries in Africa
1
Zimbabwe (53.1%)
$5K
2
Kenya (34.0%)
$3K
3
Burkina Faso (10.3%)
$1K
4
Cameroon (2.2%)
$226.74
5
Egypt (0.3%)
$34.85
6
DR Congo (0.0%)
$0.862
Top 8 Indian suppliers into Africa
1
3S PHARMACEUTICALS INDIA PVT LTD
$5K
2
R.S. SURGIPHARM PVT LTD
$2K
3
RMPL PHARMA LLP
$1K
4
SANSKRUTI PHARMA
$1K
5
RUTVA MEDICARE
$561.28
6
MELON GLOBALCARE
$226.74
7
J.A. UNITED EXPORTS PVT LTD
$34.85
8
YOGI CARE PHARMACEUTICAL PVT LTD
$0.862
Top 3 Africa importers
1
FOR THE ORDER OF* · Zimbabwe
$3K
2
/FOR THE ORDER OF · Zimbabwe
$2K
3
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Egypt
$34.85
Top 2 dosage forms
1
Tablet
$10K
2
Unknown
$561.28
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $562.14 | $281.07 |
| Nov | 5 | $2K | $461.43 |
| Dec | 8 | $7K | $909.45 |
Shipment register · 15 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — 3S PHARMACEUTICALS INDIA PVT LTD · 2 shipments · $5K | |||||||||||
| 1 | Dec 2025 | FOR THE ORDER OF* | Zimbabwe | Tablet | 19 | NOS | $166.04 | $3K | MUMBAI AIR (SAHAR) | HARARE | AIR |
| 2 | Dec 2025 | /FOR THE ORDER OF | Zimbabwe | Tablet | 11 | NOS | $152.03 | $2K | MUMBAI AIR (SAHAR) | HARARE | AIR |
| SUPPLIER #2 — R.S. SURGIPHARM PVT LTD · 2 shipments · $2K | |||||||||||
| 3 | Dec 2025 | UNKNOWN BUYER | Kenya | Tablet | 20 | PCS | $93.71 | $2K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 4 | Dec 2025 | UNKNOWN BUYER | Kenya | Tablet | 10 | PCS | $30.60 | $305.97 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #3 — RMPL PHARMA LLP · 1 shipments · $1K | |||||||||||
| 5 | Nov 2025 | UNLISTED BUYER | Kenya | Tablet | 30 | NOS | $42.46 | $1K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #4 — SANSKRUTI PHARMA · 5 shipments · $1K | |||||||||||
| 6 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 2 | NOS | $51.46 | $102.92 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 7 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 2 | NOS | $49.48 | $98.96 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 8 | Nov 2025 | UNKNOWN BUYER | Burkina Faso | Tablet | 2 | NOS | $49.48 | $98.96 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 9 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 14 | NOS | $52.33 | $732.61 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 10 | Dec 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 12 | NOS | $0.558 | $6.69 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #5 — RUTVA MEDICARE · 1 shipments · $561.28 | |||||||||||
| 11 | Oct 2025 | UNLISTED BUYER | Zimbabwe | 8 | PCS | $70.16 | $561.28 | AHMEDABAD AIR | HARARE | AIR | |
| SUPPLIER #6 — MELON GLOBALCARE · 2 shipments · $226.74 | |||||||||||
| 12 | Dec 2025 | UNLISTED BUYER | Cameroon | Tablet | 1 | NOS | $114.49 | $114.49 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| 13 | Dec 2025 | UNLISTED BUYER | Cameroon | Tablet | 1 | NOS | $112.25 | $112.25 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #7 — J.A. UNITED EXPORTS PVT LTD · 1 shipments · $34.85 | |||||||||||
| 14 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Egypt | Tablet | 100 | NOS | $0.349 | $34.85 | MUMBAI AIR (SAHAR) | CAIRO | AIR |
| SUPPLIER #8 — YOGI CARE PHARMACEUTICAL PVT LTD · 1 shipments · $0.862 | |||||||||||
| 15 | Oct 2025 | UNLISTED BUYER | DR Congo | Tablet | 2 | NOS | $0.431 | $0.862 | AHMEDABAD AIR | LUMBUMBASHI | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
9 countries · 26 shipments · $91K · 10 Indian suppliers · 8 buyers
SHIPMENTS
26
USD
$91K
COUNTRIES
9
SUPPLIERS
10
BUYERS
8
HHI
5,797
concentrated
Top 9 destination countries in Asia
1
South Korea (75.0%)
$68K
2
Myanmar (9.9%)
$9K
3
Sri Lanka (7.3%)
$7K
4
Yemen (3.4%)
$3K
5
Azerbaijan (3.3%)
$3K
6
United Arab Emirates (0.6%)
$581.31
7
Malaysia (0.3%)
$293.74
8
Iraq (0.1%)
$122.39
9
China (0.1%)
$78.18
Top 10 Indian suppliers into Asia
1
SANDOZ PVT LTD
$68K
2
WELLNESS PHARMA INTERNATIONAL
$9K
3
PLEASANT EXPORTS
$7K
4
J.A. UNITED EXPORTS PVT LTD
$3K
5
LEOWIN HEALTHCARE LLP
$3K
6
SEATRACK INTERNATIONAL TRADEX PVT LTD
$297.49
7
RUTVA MEDICARE
$293.74
8
HUMANKIND PHARMA
$283.83
9
HEET HEALTHCARE PVT LTD
$122.39
10
DRREDDYS LABORATORIES LTD
$78.18
Top 6 Asia importers
1
LEE HEE YOUNG · South Korea
$34K
2
THE ESSES PHARMACY (PVT) LTD · Sri Lanka
$7K
3
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Yemen
$3K
4
ZMC EXPRESS CARGO FZCO · United Arab Emirates
$581.31
5
TONG LOGISTICS CO LTD · China
$39.09
6
DR REDDYS (BEIJING) PHARMACEUTICA · China
$39.09
Top 2 dosage forms
1
Tablet
$91K
2
Unknown
$293.74
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 5 | $3K | $679.69 |
| Nov | 10 | $75K | $7K |
| Dec | 11 | $13K | $1K |
Shipment register · 26 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — SANDOZ PVT LTD · 4 shipments · $68K | |||||||||||
| 1 | Nov 2025 | LEE HEE YOUNG | South Korea | Tablet | 3.2K | PCS | $5.09 | $16K | MUMBAI AIR (SAHAR) | SEOUL - INCHEON INT' | AIR |
| 2 | Nov 2025 | UNKNOWN BUYER | South Korea | Tablet | 3.2K | PCS | $5.09 | $16K | MUMBAI AIR (SAHAR) | SEOUL - INCHEON INT' | AIR |
| 3 | Nov 2025 | LEE HEE YOUNG | South Korea | Tablet | 3.2K | PCS | $5.48 | $18K | MUMBAI AIR (SAHAR) | SEOUL - INCHEON INT' | AIR |
| 4 | Nov 2025 | UNKNOWN BUYER | South Korea | Tablet | 3.2K | PCS | $5.48 | $18K | MUMBAI AIR (SAHAR) | SEOUL - INCHEON INT' | AIR |
| SUPPLIER #2 — WELLNESS PHARMA INTERNATIONAL · 1 shipments · $9K | |||||||||||
| 5 | Dec 2025 | UNLISTED BUYER | Myanmar | Tablet | 10 | NOS | $904.00 | $9K | MUMBAI AIR (SAHAR) | YANGON | AIR |
| SUPPLIER #3 — PLEASANT EXPORTS · 3 shipments · $7K | |||||||||||
| 6 | Oct 2025 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | Tablet | 50 | NOS | $66.41 | $3K | CHENNAI AIR | COLOMBO | AIR |
| 7 | Dec 2025 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | Tablet | 18 | NOS | $16.51 | $297.25 | CHENNAI AIR | COLOMBO | AIR |
| 8 | Dec 2025 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | Tablet | 50 | NOS | $60.63 | $3K | CHENNAI AIR | COLOMBO | AIR |
| SUPPLIER #4 — J.A. UNITED EXPORTS PVT LTD · 1 shipments · $3K | |||||||||||
| 9 | Nov 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Tablet | 100 | NOS | $30.73 | $3K | MUMBAI AIR (SAHAR) | ADEN | AIR |
| SUPPLIER #5 — LEOWIN HEALTHCARE LLP · 2 shipments · $3K | |||||||||||
| 10 | Nov 2025 | UNLISTED BUYER | Azerbaijan | Tablet | 10 | NOS | $149.74 | $1K | MUMBAI AIR (SAHAR) | BAKU | AIR |
| 11 | Nov 2025 | UNKNOWN BUYER | Azerbaijan | Tablet | 10 | NOS | $149.74 | $1K | MUMBAI AIR (SAHAR) | BAKU | AIR |
| SUPPLIER #6 — SEATRACK INTERNATIONAL TRADEX PVT LTD · 1 shipments · $297.49 | |||||||||||
| 12 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 5 | NOS | $59.50 | $297.49 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #7 — RUTVA MEDICARE · 1 shipments · $293.74 | |||||||||||
| 13 | Dec 2025 | UNLISTED BUYER | Malaysia | 2 | NOS | $146.87 | $293.74 | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR | |
| SUPPLIER #8 — HUMANKIND PHARMA · 8 shipments · $283.83 | |||||||||||
| 14 | Nov 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 20 | NOS | $12.10 | $242.01 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 15 | Nov 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 20 | NOS | $0.330 | $6.59 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 16 | Nov 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 20 | NOS | $0.330 | $6.59 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 17 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 20 | NOS | $0.296 | $5.92 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 18 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 20 | NOS | $0.296 | $5.92 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 19 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 20 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 20 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 20 | NOS | $0.420 | $8.40 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 21 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 20 | NOS | $0.420 | $8.40 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| SUPPLIER #9 — HEET HEALTHCARE PVT LTD · 1 shipments · $122.39 | |||||||||||
| 22 | Dec 2025 | UNLISTED BUYER | Iraq | Tablet | 2 | NOS | $61.19 | $122.39 | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #10 — DRREDDYS LABORATORIES LTD · 4 shipments · $78.18 | |||||||||||
| 23 | Oct 2025 | TONG LOGISTICS CO LTD | China | Tablet | 1 | NOS | $19.54 | $19.54 | HYDERABAD AIR | CHONGQING | AIR |
| 24 | Oct 2025 | TONG LOGISTICS CO LTD | China | Tablet | 1 | NOS | $19.54 | $19.54 | HYDERABAD AIR | CHONGQING | AIR |
| 25 | Oct 2025 | DR REDDYS (BEIJING) PHARMACEUTICA | China | Tablet | 1 | NOS | $19.54 | $19.54 | HYDERABAD AIR | SHANGHAI - PU DONG | AIR |
| 26 | Oct 2025 | DR REDDYS (BEIJING) PHARMACEUTICA | China | Tablet | 1 | NOS | $19.54 | $19.54 | HYDERABAD AIR | SHANGHAI - PU DONG | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
3 countries · 9 shipments · $3K · 4 Indian suppliers · 3 buyers
SHIPMENTS
9
USD
$3K
COUNTRIES
3
SUPPLIERS
4
BUYERS
3
HHI
6,620
concentrated
Top 3 destination countries in Europe
1
Poland (86.9%)
$3K
2
Germany (12.7%)
$379.79
3
Greece (0.4%)
$12.28
Top 4 Indian suppliers into Europe
1
HEET HEALTHCARE PVT LTD
$2K
2
SACRED LEAVES PVT LTD
$379.79
3
LEOWIN HEALTHCARE LLP
$203.99
4
SUSHEN MEDICAMENTOS PVT LTD
$12.28
Top 2 Europe importers
1
SOVEREIGN SPEED FRA GMBH · Germany
$379.79
2
PHAROS LTD · Greece
$12.28
Top 3 dosage forms
1
Unknown
$2K
2
Tablet
$593.22
3
Powder
$2.84
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 7 | $3K | $396.93 |
| Dec | 2 | $213.43 | $106.71 |
Shipment register · 9 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — HEET HEALTHCARE PVT LTD · 3 shipments · $2K | |||||||||||
| 1 | Nov 2025 | UNLISTED BUYER | Poland | 5 | NOS | $159.73 | $798.63 | AHMEDABAD AIR | WARSAW | AIR | |
| 2 | Nov 2025 | UNLISTED BUYER | Poland | 5 | NOS | $159.73 | $798.63 | AHMEDABAD AIR | WARSAW | AIR | |
| 3 | Nov 2025 | UNLISTED BUYER | Poland | 5 | NOS | $159.73 | $798.63 | AHMEDABAD AIR | WARSAW | AIR | |
| SUPPLIER #2 — SACRED LEAVES PVT LTD · 3 shipments · $379.79 | |||||||||||
| 4 | Nov 2025 | SOVEREIGN SPEED FRA GMBH | Germany | Tablet | 8 | PCS | $0.0000 | $0.0000 | DELHI AIR | FRANKFURT/MAIN INT'L | AIR |
| 5 | Nov 2025 | SOVEREIGN SPEED FRA GMBH | Germany | Tablet | 8 | PCS | $0.0000 | $0.0000 | DELHI AIR | FRANKFURT/MAIN INT'L | AIR |
| 6 | Nov 2025 | SOVEREIGN SPEED FRA GMBH | Germany | Tablet | 8 | PCS | $47.47 | $379.79 | DELHI AIR | FRANKFURT/MAIN INT'L | AIR |
| SUPPLIER #3 — LEOWIN HEALTHCARE LLP · 1 shipments · $203.99 | |||||||||||
| 7 | Dec 2025 | UNLISTED BUYER | Poland | Tablet | 5 | NOS | $40.80 | $203.99 | AHMEDABAD AIR | WARSAW | AIR |
| SUPPLIER #4 — SUSHEN MEDICAMENTOS PVT LTD · 2 shipments · $12.28 | |||||||||||
| 8 | Nov 2025 | PHAROS LTD | Greece | Powder | 64 | GMS | $0.044 | $2.84 | AHMEDABAD AIR | ATHENS | AIR |
| 9 | Dec 2025 | PHAROS LTD | Greece | Tablet | 1 | NOS | $9.44 | $9.44 | AHMEDABAD AIR | ATHENS | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
4 countries · 23 shipments · $342K · 11 Indian suppliers · 8 buyers
SHIPMENTS
23
USD
$342K
COUNTRIES
4
SUPPLIERS
11
BUYERS
8
HHI
8,549
concentrated
Top 4 destination countries in Americas
1
Venezuela (93.6%)
$320K
2
Jamaica (3.5%)
$12K
3
Brazil (2.3%)
$8K
4
Bahamas (0.6%)
$2K
Top 11 Indian suppliers into Americas
1
AMRS HEALTHCARE PVT LTD
$315K
2
SHREE KRISHNA LIFECARE
$12K
3
SANSKRUTI PHARMA
$7K
4
GALAXY SUPER SPECIALITY
$4K
5
3S PHARMACEUTICALS INDIA PVT LTD
$1K
6
SPR ONCOCARE PVT LTD
$896.56
7
VAMA LIFECARE PVT LTD
$623.29
8
IKRIS PHARMA NETWORK PVT LTD
$275.38
9
SPECIALITY MEDICINES LTD
$71.16
10
NIVIRA EXPORTS
$6.01
11
DISTINCT IMPEX PVT LTD
$4.78
Top 6 Americas importers
1
JACQUELINE BROWN-BARNES · Jamaica
$12K
2
FOR THE ORDER OF · Bahamas
$1K
3
PROGRESSIVE PHARMACEUTICAL DISTRIBU · Bahamas
$896.56
4
TO THE · Brazil
$623.29
5
MARILYN LAMEY · Jamaica
$8.41
6
SELMA APARECIDA DE ASSIS · Brazil
$6.01
Top 1 dosage forms
1
Tablet
$342K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 17 | $329K | $19K |
| Dec | 6 | $12K | $2K |
Shipment register · 23 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — AMRS HEALTHCARE PVT LTD · 11 shipments · $315K | |||||||||||
| 1 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 17.7K | NOS | $1.62 | $29K | DELHI AIR | CARACAS | AIR |
| 2 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 17.7K | NOS | $1.62 | $29K | DELHI AIR | CARACAS | AIR |
| 3 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 17.7K | NOS | $1.62 | $29K | DELHI AIR | CARACAS | AIR |
| 4 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 18.0K | NOS | $1.62 | $29K | DELHI AIR | CARACAS | AIR |
| 5 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 17.7K | NOS | $1.62 | $29K | DELHI AIR | CARACAS | AIR |
| 6 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 17.7K | NOS | $1.62 | $29K | DELHI AIR | CARACAS | AIR |
| 7 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 17.7K | NOS | $1.62 | $29K | DELHI AIR | CARACAS | AIR |
| 8 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 17.7K | NOS | $1.62 | $29K | DELHI AIR | CARACAS | AIR |
| 9 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 17.7K | NOS | $1.62 | $29K | DELHI AIR | CARACAS | AIR |
| 10 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 17.7K | NOS | $1.62 | $29K | DELHI AIR | CARACAS | AIR |
| 11 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 17.7K | NOS | $1.62 | $29K | DELHI AIR | CARACAS | AIR |
| SUPPLIER #2 — SHREE KRISHNA LIFECARE · 2 shipments · $12K | |||||||||||
| 12 | Dec 2025 | JACQUELINE BROWN-BARNES | Jamaica | Tablet | 6 | NOS | $2K | $12K | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| 13 | Dec 2025 | MARILYN LAMEY | Jamaica | Tablet | 2 | NOS | $4.20 | $8.41 | MUMBAI AIR (SAHAR) | KINGSTON | SEA |
| SUPPLIER #3 — SANSKRUTI PHARMA · 2 shipments · $7K | |||||||||||
| 14 | Nov 2025 | UNLISTED BUYER | Brazil | Tablet | 48 | NOS | $73.10 | $4K | MUMBAI AIR (SAHAR) | Guarulhos | AIR |
| 15 | Nov 2025 | UNKNOWN BUYER | Brazil | Tablet | 48 | NOS | $73.10 | $4K | MUMBAI AIR (SAHAR) | Guarulhos | AIR |
| SUPPLIER #4 — GALAXY SUPER SPECIALITY · 1 shipments · $4K | |||||||||||
| 16 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 25 | NOS | $164.49 | $4K | DELHI AIR | MADRID | AIR |
| SUPPLIER #5 — 3S PHARMACEUTICALS INDIA PVT LTD · 1 shipments · $1K | |||||||||||
| 17 | Nov 2025 | FOR THE ORDER OF | Bahamas | Tablet | 20 | NOS | $50.89 | $1K | MUMBAI AIR (SAHAR) | NASSAU | AIR |
| SUPPLIER #6 — SPR ONCOCARE PVT LTD · 1 shipments · $896.56 | |||||||||||
| 18 | Nov 2025 | PROGRESSIVE PHARMACEUTICAL DISTRIBU | Bahamas | Tablet | 12 | NOS | $74.71 | $896.56 | BANGALORE AIR | NASSAU | AIR |
| SUPPLIER #7 — VAMA LIFECARE PVT LTD · 1 shipments · $623.29 | |||||||||||
| 19 | Nov 2025 | TO THE | Brazil | Tablet | 4 | NOS | $155.82 | $623.29 | MUMBAI AIR (SAHAR) | Viracopos | AIR |
| SUPPLIER #8 — IKRIS PHARMA NETWORK PVT LTD · 1 shipments · $275.38 | |||||||||||
| 20 | Dec 2025 | UNLISTED BUYER | Brazil | Tablet | 2 | NOS | $137.69 | $275.38 | DELHI AIR | Guarulhos | AIR |
| SUPPLIER #9 — SPECIALITY MEDICINES LTD · 1 shipments · $71.16 | |||||||||||
| 21 | Dec 2025 | UNLISTED BUYER | Brazil | Tablet | 2 | SET | $35.58 | $71.16 | MUMBAI AIR (SAHAR) | Guarulhos | SEA |
| SUPPLIER #10 — NIVIRA EXPORTS · 1 shipments · $6.01 | |||||||||||
| 22 | Dec 2025 | SELMA APARECIDA DE ASSIS | Brazil | Tablet | 6 | NOS | $1.00 | $6.01 | MUMBAI AIR (SAHAR) | Guarulhos | AIR |
| SUPPLIER #11 — DISTINCT IMPEX PVT LTD · 1 shipments · $4.78 | |||||||||||
| 23 | Dec 2025 | UNLISTED BUYER | Jamaica | Tablet | 6 | NOS | $0.797 | $4.78 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 1 shipments · $9.91 · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$9.91
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
New Zealand (100.0%)
$9.91
Top 1 Indian suppliers into Oceania
1
VISHAKHA IMPEX
$9.91
Top 1 Oceania importers
1
ALAIN DESIRE VICTOR DAGBA · New Zealand
$9.91
Top 1 dosage forms
1
Tablet
$9.91
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 1 | $9.91 | $9.91 |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — VISHAKHA IMPEX · 1 shipments · $9.91 | |||||||||||
| 1 | Dec 2025 | ALAIN DESIRE VICTOR DAGBA | New Zealand | Tablet | 10 | NOS | $0.991 | $9.91 | MUMBAI AIR (SAHAR) | AUCKLAND | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 28 Indian olaparib exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped olaparib in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | AMRS HEALTHCARE PVT LTD | NOIDA | 11 | $315K | Tablet | Americas |
| 2 | SANDOZ PVT LTD | Navi Mumbai | 4 | $68K | Tablet | Asia |
| 3 | SHREE KRISHNA LIFECARE | MULUND WEST | 2 | $12K | Tablet | Americas |
| 4 | WELLNESS PHARMA INTERNATIONAL | MUMBAI | 1 | $9K | Tablet | Asia |
| 5 | SANSKRUTI PHARMA | SURAT | 7 | $8K | Tablet | Africa, Americas |
| 6 | PLEASANT EXPORTS | CHENNAI | 3 | $7K | Tablet | Asia |
| 7 | 3S PHARMACEUTICALS INDIA PVT LTD | MUMBAI | 3 | $6K | Tablet | Americas, Africa |
| 8 | GALAXY SUPER SPECIALITY | NEW DELHI | 1 | $4K | Tablet | Americas |
| 9 | LEOWIN HEALTHCARE LLP | GANDHINAGAR | 3 | $3K | Tablet | Asia, Europe |
| 10 | J.A. UNITED EXPORTS PVT LTD | VASHI | 2 | $3K | Tablet | Asia, Africa |
| 11 | HEET HEALTHCARE PVT LTD | AHMEDABAD | 4 | $3K | Tablet | Europe, Asia |
| 12 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 2 | $2K | Tablet | Africa |
| 13 | RMPL PHARMA LLP | MUMBAI | 1 | $1K | Tablet | Africa |
| 14 | SPR ONCOCARE PVT LTD | BANGALORE | 1 | $896.56 | Tablet | Americas |
| 15 | RUTVA MEDICARE | SURAT | 2 | $855.02 | Africa, Asia | |
| 16 | VAMA LIFECARE PVT LTD | MUMBAI | 1 | $623.29 | Tablet | Americas |
| 17 | SACRED LEAVES PVT LTD | NEW DELHI | 3 | $379.79 | Tablet | Europe |
| 18 | SEATRACK INTERNATIONAL TRADEX PVT LTD | NEW DELHI | 1 | $297.49 | Tablet | Asia |
| 19 | HUMANKIND PHARMA | Mumbai | 8 | $283.83 | Tablet | Asia |
| 20 | IKRIS PHARMA NETWORK PVT LTD | NOIDA | 1 | $275.38 | Tablet | Americas |
| 21 | MELON GLOBALCARE | MUMBAI | 2 | $226.74 | Tablet | Africa |
| 22 | DRREDDYS LABORATORIES LTD | HYDERABAD | 4 | $78.18 | Tablet | Asia |
| 23 | SPECIALITY MEDICINES LTD | MUMBAI | 1 | $71.16 | Tablet | Americas |
| 24 | SUSHEN MEDICAMENTOS PVT LTD | AHMEDABAD | 2 | $12.28 | Powder, Tablet | Europe |
| 25 | VISHAKHA IMPEX | NAGPUR | 1 | $9.91 | Tablet | Oceania |
| 26 | NIVIRA EXPORTS | MUMBAI | 1 | $6.01 | Tablet | Americas |
| 27 | DISTINCT IMPEX PVT LTD | MUMBAI | 1 | $4.78 | Tablet | Americas |
| 28 | YOGI CARE PHARMACEUTICAL PVT LTD | AHMEDABAD | 1 | $0.862 | Tablet | Africa |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 17 global olaparib importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian olaparib in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | LEE HEE YOUNG | South Korea | 2 | $34K | SANDOZ PVT LTD | Tablet |
| 2 | JACQUELINE BROWN-BARNES | Jamaica | 1 | $12K | SHREE KRISHNA LIFECARE | Tablet |
| 3 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | 3 | $7K | PLEASANT EXPORTS | Tablet |
| 4 | FOR THE ORDER OF* | Zimbabwe | 1 | $3K | 3S PHARMACEUTICALS I… | Tablet |
| 5 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | 2 | $3K | J.A. UNITED EXPORTS … | Tablet |
| 6 | /FOR THE ORDER OF | Zimbabwe | 1 | $2K | 3S PHARMACEUTICALS I… | Tablet |
| 7 | FOR THE ORDER OF | Bahamas | 1 | $1K | 3S PHARMACEUTICALS I… | Tablet |
| 8 | PROGRESSIVE PHARMACEUTICAL DISTRIBU | Bahamas | 1 | $896.56 | SPR ONCOCARE PVT LTD | Tablet |
| 9 | TO THE | Brazil | 1 | $623.29 | VAMA LIFECARE PVT LTD | Tablet |
| 10 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | 9 | $581.31 | SEATRACK INTERNATION… | Tablet |
| 11 | SOVEREIGN SPEED FRA GMBH | Germany | 3 | $379.79 | SACRED LEAVES PVT LTD | Tablet |
| 12 | TONG LOGISTICS CO LTD | China | 2 | $39.09 | DRREDDYS LABORATORIE… | Tablet |
| 13 | DR REDDYS (BEIJING) PHARMACEUTICA | China | 2 | $39.09 | DRREDDYS LABORATORIE… | Tablet |
| 14 | PHAROS LTD | Greece | 2 | $12.28 | SUSHEN MEDICAMENTOS … | Powder, Tablet |
| 15 | ALAIN DESIRE VICTOR DAGBA | New Zealand | 1 | $9.91 | VISHAKHA IMPEX | Tablet |
| 16 | MARILYN LAMEY | Jamaica | 1 | $8.41 | SHREE KRISHNA LIFECARE | Tablet |
| 17 | SELMA APARECIDA DE ASSIS | Brazil | 1 | $6.01 | NIVIRA EXPORTS | Tablet |
This report covers 74 2025-Q4 Olaparib shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/olaparib
Talk to our trade analyst
Need a custom olaparib report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/olaparib
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Olaparib product page
Live data, supplier directory, price trends, and trade route analysis